Component

Incident diabetes mellitus

New-onset diabetes recorded during trial follow-up.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Statin therapy was associated with a 9 percent increased risk of incident diabetes across 13 randomised trials.

    Experimental context and source evidence
    duration
    Mean 4 years
    evidence_access
    Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    experimental_model
    Meta-analysis of 13 statin trials with 91,140 participants, of whom 4,278 developed diabetes
    exposure
    Statin therapy in trials of more than 1,000 patients lasting more than one year
    limitations
    A class-level association across statins and doses, not an atorvastatin-specific or mechanism-specific result, and derived from trials whose primary endpoints were cardiovascular.
    organism
    Meta-analysis of 13 statin trials with 91,140 participants, of whom 4,278 developed diabetes
    plain_language
    Statin therapy was associated with a 9 percent increased risk of incident diabetes across 13 randomised trials.
    primary_references
    Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. (2010). https://pubmed.ncbi.nlm.nih.gov/20167359/ DOI: 10.1016/S0140-6736(09)61965-6
    route
    Oral
    tissue
    New-onset diabetes mellitus

    Atorvastatin: mechanism of action from target occupancy to isoprenoids, transport, muscle and metabolism (2026-09-22) · lines 188–197

    Original AI-assisted curation of twelve primary studies resolved by PubMed title search and cross-checked against live PubMed metadata. Findings obtained with mevastatin, simvastatin or the statin class are recorded against those subjects. Study-specific citations, doses, negative findings and limitations retained. Not publisher full text. · supports · · source_derived_draft · unverified_draft

    ## statin-therapy-and-incident-diabetes Statin therapy was associated with a 9 percent increased risk of incident diabetes across 13 randomised trials. Model/species: Meta-analysis of 13 statin trials with 91,140 participants, of whom 4,278 developed diabetes Tissue/system: New-onset diabetes mellitus Exposure: Statin therapy in trials of more than 1,000 patients lasting more than one year Route: Oral Duration: Mean 4 years Limits: A class-level association across statins and doses, not an atorvastatin-specific or mechanism-specific result, and derived from trials whose primary endpoints were cardiovascular. Primary reference: Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. (2010). https://pubmed.ncbi.nlm.nih.gov/20167359/ DOI: 10.1016/S0140-6736(09)61965-6 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards